[1] 徐宏耀,王平凡,梁志强,等.心瓣膜置换术的影响因素分析[J].中国胸心血管外科临床杂志,2009,16(4):322-324.[2] 黄文聪,李勇生,钟标,等. 重症心脏瓣膜病瓣膜置换术后早期死亡率因素分析[J]. 中国当代医药,2013,20(28):35-37. [3] Kuduvalli M,Grayson AD,Au J,et al.A multi-centre additive and logistic risk model for in-hospital mortality following aortic valve replacement. Eur J Cardiothorac Surg. 2007;31(4): 607-613.[4] 孟毅,董逸飞,董书强,等.老年心脏瓣膜置换早期死亡原因及相关因素分析[J].实用老年医学,2011,25(4):321-322.[5] 章岳峰,赵琦峰,胡超. 老年心脏瓣膜置换术患者的临床分析[J].中华老年医学杂志,2013,32(1):22-24.[6] Florath I, Rosendahl UP, Mortasawi A, et al. Current determinants of operative mortality in 1400 patients requiring aortic valve replacement. Ann Thorac Surg. 2003;76(1):75-83.[7] Astor BC, Kaczmarek RG, Hefflin B, et al. Mortality after aortic valve replacement: results from a nationally representative database. Ann Thorac Surg. 2000;70(6):1939-1945.[8] 李树松,方海宁,谭伟,等.老年人心脏瓣膜病的围手术期处理[J].中国体外循环杂志,2012,10(1):48-50.[9] Eggebrecht H, Schäfer U, Treede H,et al. Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves.JACC Cardiovasc Interv. 2011; 4(11):1218-1227. [10] Bakaeen FG,Chu D,Huh J,et al. Is an age of 80 years or greater an important predictor of short-term outcomes of isolated aortic valve replacement in veterans? Ann Thorac Surg. 2010;90(3):769-774.[11] Szabo TA, Toole JM, Payne KJ, et al. Management of aortic valve bypass surgery.Semin Cardiothorac Vasc Anesth. 2012; 16(1):52-58.[12] 段亮,肖明第,袁忠祥,等. 同期行冠状动脉旁路移植及心瓣膜置换术80例[J].中国胸心血管外科临床杂志,2007,14(3): 169-172.[13] 周青云,邵国丰,史信宝,等. 冠状动脉旁路移植同期行心脏瓣膜置换手术的临床分析[J]. 现代实用医学,2012,24(7):778-779.[14] Maslow A, Casey P, Poppas A, et al. Aortic valve replacement with or without coronary artery bypass graft surgery: the risk of surgery in patients > or =80 years old. J Cardiothorac Vasc Anesth. 2010;24(1):18-24.[15] 陈林,肖颖彬,肖娟,等.不同心肌保护方法在双瓣膜置换术中对心肌的保护作用[J].中国胸心血管外科临床杂志,2012, 19(4): 371-375.[16] 姜胜利,高长青,李伯君,等. 70岁以上老年患者的心脏瓣膜手术[J].中华胸心血管外科杂志,2012,28(3):146-148.[17] Zingone B,Gatti G,Rauber E,et al.Early and late outcomes of cardiac surgery in octogenarians. Ann Thorac Surg. 2009; 87(1): 71-78.[18] 衡艳艳,方艺,钟一红,等. 1113例心脏瓣膜置换手术后急性肾损伤的临床分析[J].中华肾脏病杂志,2011,27(3):181-185.[19] Jin R, Grunkemeier GL, Starr A, et al. Validation and refinement of mortality risk models for heart valve surgery. Ann Thorac Surg.2005;80(2):471-479.[20] Maisano F, Godino C, Giacomini A, et al. Clinical trial experience with the MitraClip catheter based mitral valve repair system. Int J Cardiovasc Imaging. 2011;27(8): 1155-1164.[21] 李旭,凌峰,杨绍军,等. 16例心脏瓣膜置换术后患者死亡原因分析[J]. 中国心血管病研究,2013,11(1):27-29.[22] Ariyaratne TV, Billah B, Yap CH, et al. An Australian risk prediction model for determining early mortality following aortic valve replacement. Eur J Cardiothorac Surg. 2011; 39(6):815-821.[23] Reid C, Billah B, Dinh D, et al. An Australian risk prediction model for 30-day mortality after isolated coronary artery bypass: the AusSCORE. J Thorac Cardiovasc Surg. 2009; 138(4):904-910.[24] 李悟,王忠华,王卫东.巨大左心室瓣膜置换术32例临床分析[J].临床军医杂志,2012,40(2):263-265.[25] 祝岩,王辉山,汪曾炜,等. 二尖瓣置换术后左室破裂的外科处理[J]. 中华胸心血管外科杂志,2012,28(8):449-452.[26] 伍育旗,余旻,井景,等. 冠状动脉旁路移植术后延迟脱呼吸机时间的危险因素[J]. 心脏杂志,2013,24(4):430-432.[27] 丁凯,周华富,覃家锦,等. 心瓣膜置换术后患者围术期死亡原因分析[J]. 中国胸心血管外科临床杂志,2011,18(1):80-82.[28] Rahmanian PB, Adams DH, Castillo JG, et al. Predicting hospital mortality and analysis of long-term survival after major noncardiac complications in cardiac surgery patients. Ann Thorac Surg. 2010;90(4):1221-1229.[29] 许建屏,史艺,葛翼鹏,等.瓣膜手术后呼吸功能衰竭的危险因素分析[J].中华胸心血管外科杂志,2006,22(4):217-219.[30] Roques F, Nashef SA, Michel P, et al. Regional differences in surgical heart valve disease in Europe: comparison between northern and southern subsets of the EuroSCORE database. J Heart Valve Dis. 2003;12(1):1-6.[31] Manne MB, Shrestha NK, Lytle BW, et al. Outcomes after surgical treatment of native and prosthetic valve infective endocarditis.Ann ThoracSurg. 2012;93(2):489-493.[32] 李蕾,杨恒,骆宏,等. 重症换瓣病人依托咪酯麻醉诱导对血流动力学的影响[J]. 皖南医学院学报,2013,32(4):330-331.[33] 李道麟,董平栓,杜来景, 等. 心脏瓣膜置换术后肺部感染的相关危险因素分析[J]. 中华医院感染学杂志,2013,23(16): 3908-3910.[34] Rajaei S, Dabbagh A. Risk Factors for Postoperative Respiratory Mortality and Morbidity in Patients Undergoing Coronary Artery Bypass Grafting. Anesth Pain Med. 2012; 2(2):60-65.[35] 孟浩宇,张敏,陈彭生,等. 经皮冠状动脉介入治疗与冠状动脉旁路移植术对无保护左主干病变患者的疗效和预后对比分析及Syntax积分的价值[J]. 中国介入心脏病学杂志,2013,20(4): 205-211.[36] 孙立新,王强,王明山,等. 双侧胸椎旁神经阻滞对体外循环下冠状动脉旁路移植术中的心肌保护作用[J]. 中国体外循环杂志, 2013,11(3):137-140.[37] 权晓强,程兆云,孙俊杰, 等. 并行体外循环下不停跳冠状动脉旁路移植术在冠状动脉左主干病变中的应用价值[J]. 中华医学杂志,2013,93(32):2545-2548.[38] 肖志斌,姚建民,王东文, 等. 内窥镜采集大隐静脉在冠状动脉旁路移植术后近、中期的疗效分析[J]. 中国循证心血管医学杂志,2013,5(4):371-373.[39] 方继瀛. 心肌损伤标志物在冠状动脉旁路移植术中的应用研究进展[J]. 实用心脑肺血管病杂志,2013,21(9):8-9.[40] 王睿,陈鑫,徐明,等. 术前主动置入主动脉内球囊反搏在极高危冠状动脉旁路移植患者中的应用[J].中华外科杂志,2013,51(9): 808-811.[41] 王律,白一帆,刘小刚,等. 主动脉瓣及二尖瓣机械瓣联合置换术后瓣膜不匹配现象的临床研究[J].实用医学杂志,2013,29(9): 1448-1450.[42] Pibarot P, Dumesnil J G. Valve prosthesis-patient mismatch, 1978 to 2011: from original concept to compelling evidence. J Am Coil Cardiol. 2012;60(13):1136-1139.[43] 渠川铮,张瑞英,相开放. 心脏瓣膜置换围手术期血糖控制对血乳酸水平的影响[J].中国组织工程研究,2012,16(53): 9955- 9959.[44] 侯园园,周萍. 心胸比率对心脏瓣膜置换后影响的Meta分析[J]. 中国组织工程研究,2010,14(44):8220-8224. [45] Bening C, Weiler H, Vahl CF. Effects of gender, ejection fraction and weight on cardiac force development in patients undergoing cardiac surgery-an experimental examination. Cardiothorac Surg. 2013;8(1):214.[46] Lee CH, Shieh YS, Tsai CS, et al. Plasma concentrations predict aortic expression of growth-arrest-specific protein 6 in patients undergoing coronary artery bypass grafting. PLoS One. 2013;8(11):e79452. |